MoneyWorks4Me

Shukra Pharmaceuticals informs about disclosure

05 Apr 2024 Evaluate
Shukra Pharmaceuticals has informed that the Shareholders through postal ballot have approved the alteration to clause 5 of the Memorandum of Association (MOA) of the company. And article clause no,3B(ii)(d) of Article of Association(AoA) of the company Accordingly, the MOA of the Company has been altered as follows: The Authorized Share capital of the company is Rs 44,00,00,000 (Rupees Forty-four crore only) consisting of 4,40,0d,000 (Four Crore Forty Lakh) Equity Shares of Rs 10 each.’

The above information is a part of company’s filings submitted to BSE.

Shukra Pharmaceut. Share Price

42.60 0.91 (2.18%)
19-Aug-2026 14:51 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1894.70
Dr. Reddys Labs. 1169.75
Cipla 1419.00
Lupin 2222.00
Zydus Lifesciences 1109.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: